Meet the New AnnalsATS Editor-in-Chief

April 4, 2017 at 1:50 pm

The American Thoracic Society is pleased to announce the selection of David J Lederer, MD, MS, as editor-in-chief of the Annals of the American Thoracic Society.

Dr. Lederer is an associate professor in the Department of Medicine at Columbia University Physicians and Surgeons and the Department of Epidemiology at the Mailman School of Public Health at Columbia University. He is the associate division chief for Clinical and Translational Research and director of the Pulmonary & Intensive Care Translational Outcomes Research (PICTOR) Group in the Division of Pulmonary, Allergy, and Critical Care at Columbia.

Dr. Lederer is an NHLBI-funded clinical and epidemiological investigator whose research aims to develop methods to prevent lung fibrosis by identifying novel targetable risk factors for preclinical interstitial lung disease, and focuses on the roles of adiposity and frailty in lung injury and inflammation after lung transplantation. His research has influenced clinical practice both by raising awareness about the importance of early referral of ILD patients for subspecialty care and by modifying selection criteria and clinical reasoning behind the timing of listing of adult lung transplant candidates based on body mass index, frailty, and short stature.  He is an active clinician recognized as an expert in the care of adults with interstitial lung disease and those who have undergone lung transplantation.

He has previously served as a Deputy Editor for the Annals of the American Thoracic Society and a Statistical Editor for Thorax. He is currently the Vice-Chair of the ATS Documents Development & Implementation Committee and Chair of the ATS Clinical Problems Planning Committee. He is a standing member of two NIH study sections and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine, the ALA Scientific Advisory Board, the SRTR Visiting Committee, and is a Senior Medical Advisor on Education and Awareness for the Pulmonary Fibrosis Foundation. Dr. Lederer also runs a blog for patients with pulmonary fibrosis at

In a recent video interview, he shared his vision and goals for the Journal, which include developing it into a destination for high-quality clinical epidemiological, and health services research; continuing the growth of non-research content in order to grow its widespread appeal; and growing the commentary section to include additional topics such as public health, global health, environmental health, health care policy and financing, and biomedical ethics.

Hear more about the insights he brings to the role of editor in this new AnnalsATS podcast.


ATS 2016 Full Registration